Frazier Life Sciences Management, L.P. Edgewise Therapeutics, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.86 Billion
- Q3 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 2,832,867 shares of EWTX stock, worth $87.2 Million. This represents 4.07% of its overall portfolio holdings.
Number of Shares
2,832,867
Previous 3,731,067
24.07%
Holding current value
$87.2 Million
Previous $67.2 Million
12.52%
% of portfolio
4.07%
Previous 3.96%
Shares
7 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$462 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$274 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$185 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$180 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$171 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.94B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...